Abstract
The unique merits of aptamers, including specificity, high binding affinity, easy cell internalization, and rapid tissue accumulation abilities, have led aptamer-drug conjugates to evolve into one of the most attractive strategies for targeted drug delivery purposes. Nevertheless, the critical role of linkers in regulating anticancer efficacy of these conjugates, especially those engineered by automated modular synthesis techniques, has been rarely explored. In this work, we utilized Sgc8c aptamer and combretastatin A4 to develop three conjugates with either a phosphodiester bond linker, a disulfide bond linker, or a carbamate linker to study their payload release mechanisms and the influence on anticancer efficacy. These investigations allowed us to identify the unique activation pathway of the phosphodiester bond linker that is activated by both nucleophilic attack of glutathione and degradation caused by phosphodiesterase, which is highly associated with the higher cytotoxicity of the conjugate. Importantly, the understanding of the chemistry of phosphodiester bond linker activation allowed us to further design another XQ-2d-CA4 conjugate that can induce pancreatic cancer cells apoptosis in a more efficient manner.
References
Oct 14, 2003·Biochemical Pharmacology·Alfonso PompellaAlessandro F Casini
Feb 28, 2004·The Journal of Nutrition·Guoyao WuNancy D Turner
Sep 14, 2006·Pharmacological Reviews·Andrew T Bender, Joseph A Beavo
Sep 18, 2008·Molecular Aspects of Medicine·Henry Jay FormanAlessandra Rinna
Mar 4, 2009·Chembiochem : a European Journal of Chemical Biology·Yu-Fen HuangWeihong Tan
Jun 15, 2013·Oxidative Medicine and Cellular Longevity·Nicola TraversoCinzia Domenicotti
Feb 4, 2014·Journal of the American Chemical Society·RuoWen WangWeihong Tan
Apr 2, 2014·Nature Reviews. Drug Discovery·Donald H MauriceVincent C Manganiello
Jun 18, 2015·Bioconjugate Chemistry·Guizhi ZhuXiaoyuan Chen
Nov 2, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Ke ChenWeihong Tan
Nov 4, 2016·Nature Reviews. Drug Discovery·Jiehua Zhou, John Rossi
Mar 18, 2017·Nature Reviews. Drug Discovery·Alain BeckNathalie Corvaïa
Mar 23, 2017·Molecular Therapy. Nucleic Acids·Sorah YoonJohn J Rossi
Nov 11, 2017·Nature Communications·Fangfei LiGe Zhang
Mar 4, 2018·Molecular Therapy. Nucleic Acids·Christina Kratschmer, Matthew Levy
Apr 19, 2018·Proceedings of the National Academy of Sciences of the United States of America·Bethany Powell GrayBruce A Sullenger
Aug 24, 2018·Biomaterials·Wenjing XuanWeihong Tan
Sep 10, 2018·Molecular Therapy. Nucleic Acids·Jun Young ParkWon Jun Kang
Jun 22, 2019·Nature Communications·Cheng JinWeihong Tan
Jan 8, 2020·Journal of the American Chemical Society·Qiuxia YangWeihong Tan